Sapovirus I

Watery diarrhea and vomiting can come from a virus even when a routine stool culture finds no bacteria. This test looks for sapovirus genogroup I genetic material in stool. A positive result can help explain an episode of illness, but interpretation depends on your symptoms, when the sample was collected, and whether another cause is present.

What This Test Looks For

Sapovirus and norovirus belong to the same virus family and can cause similar symptoms. They require separate detection targets. A norovirus-only test does not detect sapovirus.

Human sapoviruses fall into four main genetic groups: GI, GII, GIV, and GV. This test targets GI. GI.1 and GI.2 are common types within that group, though the types circulating in a community change over time. A negative GI result cannot exclude infection with another sapovirus group.

Sapovirus spreads when particles from infected stool reach someone's mouth through contaminated hands, surfaces, food, or water. Stool is the specimen used to investigate intestinal infection because infected people shed viral material in it, including after symptoms have stopped.

How the Measurement Works

Sapovirus carries its genetic instructions in RNA. Detecting it by qPCR requires converting that RNA into DNA before repeatedly copying the target sequence. This approach is called reverse-transcription quantitative PCR, or RT-qPCR. It detects genetic material without establishing whether the virus in the sample can still infect someone.

The catalog lists the reporting unit as CFU/g stool. CFU stands for colony-forming units and ordinarily describes microbes that grow into colonies in culture. Sapovirus RNA testing does not count those colonies. The laboratory needs to explain what this reporting unit represents and how it was calibrated before a numerical result can be interpreted.

Published sapovirus studies often report genome copies or PCR cycle values. Those measurements cannot be converted directly into this catalog's CFU/g stool result. The catalog does not identify the assay's manufacturer, detection limit, calibration, or coverage of individual GI variants, so performance figures from another assay cannot establish this test's accuracy.

How Established Is the Test?

Stool molecular detection of sapovirus has an established role in investigating infectious diarrhea, including on clinical panels that test several pathogens at once. Interpreting a numerical sapovirus result as a measure of illness severity, contagiousness, or recovery is much less established. There is no validated clinical target for this GI-specific result in CFU/g stool.

A meta-analysis of the BioFire FilmArray gastrointestinal panel estimated 96% sensitivity and 99% specificity for sapovirus detection. That platform reports a qualitative result covering several human sapovirus groups. These estimates concern detection by that platform, not the accuracy of this GI-specific quantitative assay or the probability that sapovirus caused your symptoms.

Who Gets Sapovirus?

Most of the clinical evidence below comes from stool studies that detected several human sapovirus groups together. It describes sapovirus infection broadly and does not validate the numerical interpretation of this GI-only test.

In a birth-cohort study across eight low- and middle-income countries, more than 90% of children had a detected sapovirus infection by their second birthday. That finding reflects those study communities and all detected sapovirus groups; it is not a worldwide estimate for genogroup I.

Detection rates vary with age, location, symptoms, and the testing method. A Spanish outpatient study found sapovirus in about 16% of samples from people with acute gastroenteritis. Other settings have reported much lower rates. Sapovirus has ranked second among detected diarrheal viruses in some local studies, but that ranking does not apply everywhere that rotavirus vaccination is used.

Adults can also become infected, and outbreaks occur in care facilities, schools, and food-service settings. People with weakened immune systems can develop prolonged diarrhea.

What a Positive Result Means

A positive result means the assay detected its sapovirus target in your stool sample. Whether that finding explains your illness depends on the timing and clinical picture. Asymptomatic infection, continued shedding after recovery, and infection with another pathogen can all produce a positive result that needs further interpretation.

Symptom-free shedding is well documented in children. A Danish daycare study found sapovirus in 21% of children at their first sampling, but that figure included children with and without reported symptoms. It should not be presented as the proportion of healthy children shedding the virus.

The amount detected does not settle whether sapovirus caused the diarrhea. Some studies found more viral RNA in symptomatic infections, while others found that PCR cycle values did not reliably distinguish illness from symptom-free detection. Evidence from asymptomatic adults with high viral loads includes genogroup GIV, a different group from the GI target here.

Shedding Can Outlast the Illness

In a Peruvian birth cohort that tested for multiple sapovirus groups, the median duration of stool RNA shedding was 18.5 days. Some infections remained detectable beyond a month. These are detection periods, not proven periods of contagiousness.

Much longer detection has been reported after transplantation. In a small transplant subgroup within an adult oncology study using a broader gastrointestinal PCR panel, median sapovirus shedding lasted 97 days, with some cases extending beyond a year. That selected subgroup does not represent the expected duration for everyone with a weakened immune system.

Continued RNA detection after recovery can therefore reflect a recent infection. In someone who remains unwell, it can also accompany persistent infection. PCR alone cannot distinguish those situations or determine whether infectious virus remains.

When Results Can Be Misleading

False-positive results are possible, but their frequency depends on the assay and setting. In a 2026 evaluation of virus-positive BioFire FilmArray specimens from five US Veterans Affairs centers, 18.8% of sapovirus-positive results did not meet the study's reference-assay confirmation criteria. That is a finding about one platform and a selected sample set, not a general false-positive rate for this test.

• Small amounts of target material: a weak signal can reflect a true low-level infection or residual RNA. Contamination or non-specific amplification can also produce an unexpected result, so signal strength alone cannot classify it.
• Stool interference: substances in stool can interfere with extraction or amplification and cause a false negative. Laboratory controls help identify these problems.
• Limited genetic coverage: this test targets GI. Other sapovirus groups and GI variants that an assay does not reliably recognize can be missed.
• Collection and handling: an unsuitable container, incorrect preservative, contamination, or transport outside the laboratory's requirements can compromise the result.
• Other pathogens: detecting sapovirus does not exclude a bacterial, parasitic, or second viral infection.
• Results from different assays: extraction methods, target sequences, calibration, and reporting formats differ. Numbers from different laboratories or platforms are not automatically comparable.

How It Compares With Other Testing

Routine bacterial stool culture does not detect sapovirus. Molecular testing also detects infections that older approaches such as electron microscopy can miss. Studies comparing older diagnostics with broad molecular panels often found more viral detections, partly because the newer panels tested for additional viruses. Those gains cannot be assigned to this single GI target.

Some gastrointestinal panels report sapovirus as detected or not detected across GI, GII, GIV, and GV without identifying the group. This catalog entry is narrower. Neither a qualitative positive nor a quantitative result establishes the cause of diarrhea without the clinical context.

Why Infection Can Happen Again

Previous infection appears to provide partial protection. In the eight-country birth-cohort study, a previous sapovirus infection was associated with about a fifth lower risk of another detected infection. This was observational evidence across sapovirus groups, not proof of lasting immunity to GI.

In a smaller Nicaraguan analysis, 17 of 19 repeat symptomatic infections involved a different genotype. That pattern suggests protection may depend on the viral type, but the small number of repeat episodes limits how precisely the finding predicts your own risk.